Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8462
Reference
MSAN(2025)25
Name
Tolterodine 2mg and 4mg modified-release capsules
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Tolterodine 2mg and 4mg modified-release (MR) capsules are in limited supply until mid-August and mid-September 2025, respectively. Tolterodine 1mg and 2mg immediate release (IR) tablets remain available and can support increased demand. Alternative once-daily antimuscarinics also remain available and can support increased demand. Unlicensed imports of tolterodine MR capsules may be sourced; lead times vary.
Contact Name
Contact Address
PharmacyTeam@gov.scot
Created
2025-05-27 10:05:00
Click to go back to homepage